Lumexa Imaging Holdings, Inc. (LMRI) stock
LMRINasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$14.26+0.20 (+1.42%)
Close on Nov 20, 2026Market cap $1.37BP/E –Yield –
Lumexa Imaging net income
Net income is the profit left for shareholders after every expense, interest and tax.
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $7.18M | – |
| Q2 FY2026 | Jun 30, 2026 | $2.75M | – |
| Q1 FY2026 | Mar 31, 2026 | $1.72M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.50M | – |
| Q2 FY2025 | Jun 30, 2025 | -$7.23M | – |
| Q1 FY2025 | Mar 31, 2025 | -$7.69M | – |
See a number that looks wrong?